Zingg, W., Park, B. J., Storr, J., Ahmad, R., Tarrant, C., Castro-Sanchez, E., Perencevich, E., Widmer, A., Krause, K. H., Kilpatrick, C., Tomczyk, S., Allegranzi, B., Cardo, D., Pittet, D., Abbas, M., Andremont, A., Bell, M., Borg, M., Carmeli, Y., ... Walsh, T. (2019). Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2). Antimicrobial Resistance and Infection Control, 8(1), Article 83. https://doi.org/10.1186/s13756-019-0538-y
Zingg, W, Park, BJ, Storr, J, Ahmad, R, Tarrant, C, Castro-Sanchez, E, Perencevich, E, Widmer, A, Krause, KH, Kilpatrick, C, Tomczyk, S, Allegranzi, B, Cardo, D, Pittet, D, Abbas, M, Andremont, A, Bell, M, Borg, M, Carmeli, Y, Conly, J, Eggimann, P, Gastmeier, P, Grayson, ML, Harbarth, S, Hernandez, M, Herwaldt, L, Holmes, A, Jernigan, JA, Kolwaite, A, Larson, E, Masson-Roy, S, Mehtar, S, Mendelson, M, Lin, LM, Moldovan, A, Monnet, D, Ndoye, B, Nthumba, P, Ogunsola, F, Samore, M, Seto, WH, Srinivasan, A, Tacconelli, E, Talaat, M, Villegas, MV, Voss, A & Walsh, T 2019, 'Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2)', Antimicrobial Resistance and Infection Control, vol. 8, n° 1, 83. https://doi.org/10.1186/s13756-019-0538-y
@article{4c9e60c7660e47af9ee17bd08b3b5734,
title = "Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2)",
abstract = "Background: The high burden of healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) is partially due to excessive antimicrobial use both in human and animal medicine worldwide. How can technology help to overcome challenges in infection prevention and control (IPC) and to prevent HAI and emerging AMR? Methods: In June 2017, 42 international experts convened in Geneva, Switzerland to discuss four potential domains of technology in IPC and AMR: 1) role and potential contribution of microbiome research; 2) whole genome sequencing; 3) effectiveness and benefit of antimicrobial environmental surfaces; and 4) future research in hand hygiene. Results: Research on the microbiome could expand understanding of antimicrobial use and also the role of probiotics or even faecal transplantation for therapeutic purposes. Whole genome sequencing will provide new insights in modes of transmission of infectious diseases. Although it is a powerful tool for public health epidemiology, some challenges with interpretation and costs still need to be addressed. The effectiveness and cost-effectiveness of antimicrobially coated or treated environmental high-touch surfaces requires further research before they can be recommended for routine use. Hand hygiene implementation can be advanced, where technological enhancement of surveillance, technique and compliance are coupled with reminders for healthcare professionals. Conclusions: The four domains of technological innovation contribute to the prevention of HAI and AMR at different levels. Microbiome research may offer innovative concepts for future prevention, whole genome sequencing could detect new modes of transmission and become an additional tool for effective public health epidemiology, antimicrobial surfaces might help to decrease the environment as source of transmission but continue to raise more questions than answers, and technological innovation may have a role in improving surveillance approaches and supporting best practice in hand hygiene.",
author = "Walter Zingg and Park, {Benjamin J.} and Julie Storr and Raheelah Ahmad and Carolyn Tarrant and Enrique Castro-Sanchez and Eli Perencevich and Andreas Widmer and Krause, {Karl Heinz} and Claire Kilpatrick and Sara Tomczyk and Benedetta Allegranzi and Denise Cardo and Didier Pittet and Mohamed Abbas and Antoine Andremont and Mike Bell and Michael Borg and Yehuda Carmeli and John Conly and Philippe Eggimann and Petra Gastmeier and Grayson, {M. Lindsay} and Stephan Harbarth and Marcela Hernandez and Loreen Herwaldt and Alison Holmes and Jernigan, {John A.} and Amy Kolwaite and Elaine Larson and Sarah Masson-Roy and Shaheen Mehtar and Marc Mendelson and Lin, {Ling Moi} and Andreea Moldovan and Dominique Monnet and Babacar Ndoye and Peter Nthumba and Folasade Ogunsola and Matthew Samore and Seto, {Wing Hong} and Arjun Srinivasan and Evelina Tacconelli and Maha Talaat and Villegas, {Maria Virginia} and Andreas Voss and Tim Walsh",
note = "Publisher Copyright: {\textcopyright} 2019 The Author(s).",
year = "2019",
month = may,
day = "22",
doi = "10.1186/s13756-019-0538-y",
language = "English",
volume = "8",
journal = "Antimicrobial Resistance and Infection Control",
issn = "2047-2994",
publisher = "BioMed Central",
number = "1",
}
TY - JOUR
T1 - Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2)
AU - Zingg, Walter
AU - Park, Benjamin J.
AU - Storr, Julie
AU - Ahmad, Raheelah
AU - Tarrant, Carolyn
AU - Castro-Sanchez, Enrique
AU - Perencevich, Eli
AU - Widmer, Andreas
AU - Krause, Karl Heinz
AU - Kilpatrick, Claire
AU - Tomczyk, Sara
AU - Allegranzi, Benedetta
AU - Cardo, Denise
AU - Pittet, Didier
AU - Abbas, Mohamed
AU - Andremont, Antoine
AU - Bell, Mike
AU - Borg, Michael
AU - Carmeli, Yehuda
AU - Conly, John
AU - Eggimann, Philippe
AU - Gastmeier, Petra
AU - Grayson, M. Lindsay
AU - Harbarth, Stephan
AU - Hernandez, Marcela
AU - Herwaldt, Loreen
AU - Holmes, Alison
AU - Jernigan, John A.
AU - Kolwaite, Amy
AU - Larson, Elaine
AU - Masson-Roy, Sarah
AU - Mehtar, Shaheen
AU - Mendelson, Marc
AU - Lin, Ling Moi
AU - Moldovan, Andreea
AU - Monnet, Dominique
AU - Ndoye, Babacar
AU - Nthumba, Peter
AU - Ogunsola, Folasade
AU - Samore, Matthew
AU - Seto, Wing Hong
AU - Srinivasan, Arjun
AU - Tacconelli, Evelina
AU - Talaat, Maha
AU - Villegas, Maria Virginia
AU - Voss, Andreas
AU - Walsh, Tim
N1 - Publisher Copyright:
© 2019 The Author(s).
PY - 2019/5/22
Y1 - 2019/5/22
N2 - Background: The high burden of healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) is partially due to excessive antimicrobial use both in human and animal medicine worldwide. How can technology help to overcome challenges in infection prevention and control (IPC) and to prevent HAI and emerging AMR? Methods: In June 2017, 42 international experts convened in Geneva, Switzerland to discuss four potential domains of technology in IPC and AMR: 1) role and potential contribution of microbiome research; 2) whole genome sequencing; 3) effectiveness and benefit of antimicrobial environmental surfaces; and 4) future research in hand hygiene. Results: Research on the microbiome could expand understanding of antimicrobial use and also the role of probiotics or even faecal transplantation for therapeutic purposes. Whole genome sequencing will provide new insights in modes of transmission of infectious diseases. Although it is a powerful tool for public health epidemiology, some challenges with interpretation and costs still need to be addressed. The effectiveness and cost-effectiveness of antimicrobially coated or treated environmental high-touch surfaces requires further research before they can be recommended for routine use. Hand hygiene implementation can be advanced, where technological enhancement of surveillance, technique and compliance are coupled with reminders for healthcare professionals. Conclusions: The four domains of technological innovation contribute to the prevention of HAI and AMR at different levels. Microbiome research may offer innovative concepts for future prevention, whole genome sequencing could detect new modes of transmission and become an additional tool for effective public health epidemiology, antimicrobial surfaces might help to decrease the environment as source of transmission but continue to raise more questions than answers, and technological innovation may have a role in improving surveillance approaches and supporting best practice in hand hygiene.
AB - Background: The high burden of healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) is partially due to excessive antimicrobial use both in human and animal medicine worldwide. How can technology help to overcome challenges in infection prevention and control (IPC) and to prevent HAI and emerging AMR? Methods: In June 2017, 42 international experts convened in Geneva, Switzerland to discuss four potential domains of technology in IPC and AMR: 1) role and potential contribution of microbiome research; 2) whole genome sequencing; 3) effectiveness and benefit of antimicrobial environmental surfaces; and 4) future research in hand hygiene. Results: Research on the microbiome could expand understanding of antimicrobial use and also the role of probiotics or even faecal transplantation for therapeutic purposes. Whole genome sequencing will provide new insights in modes of transmission of infectious diseases. Although it is a powerful tool for public health epidemiology, some challenges with interpretation and costs still need to be addressed. The effectiveness and cost-effectiveness of antimicrobially coated or treated environmental high-touch surfaces requires further research before they can be recommended for routine use. Hand hygiene implementation can be advanced, where technological enhancement of surveillance, technique and compliance are coupled with reminders for healthcare professionals. Conclusions: The four domains of technological innovation contribute to the prevention of HAI and AMR at different levels. Microbiome research may offer innovative concepts for future prevention, whole genome sequencing could detect new modes of transmission and become an additional tool for effective public health epidemiology, antimicrobial surfaces might help to decrease the environment as source of transmission but continue to raise more questions than answers, and technological innovation may have a role in improving surveillance approaches and supporting best practice in hand hygiene.
UR - http://www.scopus.com/inward/record.url?scp=85067207710&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067207710&partnerID=8YFLogxK
U2 - 10.1186/s13756-019-0538-y
DO - 10.1186/s13756-019-0538-y
M3 - Article
C2 - 31139366
AN - SCOPUS:85067207710
SN - 2047-2994
VL - 8
JO - Antimicrobial Resistance and Infection Control
JF - Antimicrobial Resistance and Infection Control
IS - 1
M1 - 83
ER -
